Alessandra Iurlo

90PUBLICATIONS
187CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedMedical mycologyPredictive and prognostic markersRegenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (90)

|Jun 11, 2026
Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome.

|May 12, 2026
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

|Mar 05, 2026
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Barbara Mora, Francesca Palandri, Paola Guglielmelli

|Feb 26, 2026
Health Care Utilization Databases obtained from health system inform outcome for ruxolitinib treatment in patients with myelofibrosis.

Barbara Mora, Matteo Franchi, Ludovica Margotto

|Feb 13, 2026
Survival and quality-of-life implications of cytopenia trajectories in ruxolitinib-treated myelofibrosis.

Francesca Palandri, Giovanni Caocci, Elisabetta Abruzzese

|Jan 21, 2026
Second attempt to discontinue TKI after molecular relapse in patients with chronic myeloid leukemia: A real-life Italian multicenter study.

Alessandra Iurlo, Daniele Cattaneo, Carmen Fava

Pageof 15

Frequent Collaborators

31 joint publications

Massimo Breccia

26 joint publications

Massimiliano Bonifacio

26 joint publications

Francesca Palandri

21 joint publications

Elisabetta Abruzzese